Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

decatur memorial hospital - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - sodium fluoride f18 injection, usp is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk.  because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

sheffield pharmaceuticals llc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o), potassium nitrate (unii: ru45x2jn0z) (nitrate ion - unii:t93e9y2844) - a dental caries preventive and sensitive toothpaste; for twice daily self-applied topical use,following by rinsing, helps reduce the painful sensitivity of the teeth to cold, heat, acid, sweets or contact in adults patients and children 12 years of age and older.  it is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators.1-4  sodium fluoride 5000 ppm sensitive 1.1% sodium fluoride toothpaste with 5% potassium nitrate in a squeeze-tube is easily applied onto a toothbrush. this prescription toothpaste should be used twice daily in place of your regular toothpaste, unless otherwise instructed by your dental professional. may be used whether or not drinking water is fluoridated, since topical fluoride cannot produce fluorosis. (see warnings for exception.) do not use in pediatric patients under age 12 years unless recommended by a dentist or physician.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

sofie co. dba sofie - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - sodium fluoride f18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to defined areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fluo

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

bryant ranch prepack - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f¯) during the period of tooth development results in a significant decrease in the incidence of dental caries. sodium fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from age 3 years to age 16 years and older living in areas where the drinking water fluoride contents does not exceed 0.6 ppm f¯. fluoride 1.0 mg tablets are contraindicated when the fluoride content of drinking water is >0.3 ppm f¯ and should not be administered to pediatric patients under 6 years. fluoride 0.5 mg tablets are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f¯ and should not be administered to pediatric patients under age 6 when the fluoride content of drinking water is 0.3 ppm f¯ or more or to pediatric patients under age 3 years. fluoride 0.25 mg tablets are co

Belgia - engleză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

life radiopharma berlin gmbh - sodium fluoride (18 f) 100 mbq/ml - 4000 mbq/ml - solution for injection - 0,1-4 gbq/ml - sodium fluoride (f-18) - sodium fluoride (18f)

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

bamf health inc. - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - sodium fluoride f 18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fluoride f 18 injection or not to administer sodium fluoride f 18 injection, taking into account the importance of the drug to the mother. the body of scientific information related to radioactive decay, drug tissue distribution, and drug elimination shows that less than 0.01% of the radioactivity administered remains in the body after 24 hours (10 half-lives). to minimize the risks to a nursing infant, interrupt nursing for at least 24 hours. in reported clinical experience in approximately 100 children, weight based doses (2.1 mbq/kg) ranging from 19 mbq-148 mbq (0.5 mci-4 mci) were used. sodium fluoride f 18 was shown to localize to areas of bone turnover including rapidly growing epiphyses in developing long bones. children are more sensitive to radiation and may be at higher risk of cancer from sodium fluoride f 18 injection.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

bryant ranch prepack - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f¯) during the period of tooth development results in a significant decrease in the incidence of dental caries. sodium fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from age 3 years to age 16 years and older living in areas where the drinking water fluoride contents does not exceed 0.6 ppm f¯. fluoride 1.0 mg tablets are contraindicated when the fluoride content of drinking water is >0.3 ppm f¯ and should not be administered to pediatric patients under 6 years. fluoride 0.5 mg tablets are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f¯ and should not be administered to pediatric patients under age 6 when the fluoride content of drinking water is 0.3 ppm f¯ or more or to pediatric patients under age 3 years. fluoride 0.25 mg tablets are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f¯ and should not be administered to pediatric patients under age 3 years when the fluoride content of drinking water is 0.3 ppm f¯ or more. do not administer sodium fluoride chewable tablets (any strength) to pediatric patients under age 3 years. sodium fluoride chewable tablets (any strength) are not indicated for use in adults.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

bryant ranch prepack - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f¯) during the period of tooth development results in a significant decrease in the incidence of dental caries. sodium fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from age 3 years to age 16 years and older living in areas where the drinking water fluoride contents does not exceed 0.6 ppm f¯. fluoride 1.0 mg tablets are contraindicated when the fluoride content of drinking water is >0.3 ppm f¯ and should not be administered to pediatric patients under 6 years. fluoride 0.5 mg tablets are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f¯ and should not be administered to pediatric patients under age 6 when the fluoride content of drinking water is 0.3 ppm f¯ or more or to pediatric patients under age 3 years. fluoride 0.25 mg tablets are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f¯ and should not be administered to pediatric patients under age 3 years when the fluoride content of drinking water is 0.3 ppm f¯ or more. do not administer sodium fluoride chewable tablets (any strength) to pediatric patients under age 3 years. sodium fluoride chewable tablets (any strength) are not indicated for use in adults.

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

dent-mat holdings, llc. - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o), potassium nitrate (unii: ru45x2jn0z) (nitrate ion - unii:t93e9y2844) - fluoride ion 5 mg in 1 g - fluoridex toothpaste is indicated for use as part of a professional program for the prevention and control of dental caries. do not use in children under 12 years of age unless recommended by a dentist or physician. 8.1 pregnancy pregnancy category b it has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissues. animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. there are no adequate or well controlled clinical studies in pregnant women. however, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in chi

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

bryant ranch prepack - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - for once daily self-applied systemic use as a dental caries preventive in pediatric patients. it has been established that ingestion of fluoridated drinking water (1 ppm f¯) during the period of tooth development results in a significant decrease in the incidence of dental caries. sodium fluoride chewable tablets were developed to provide systemic fluoride for use as a supplement in pediatric patients from age 3 years to age 16 years and older living in areas where the drinking water fluoride contents does not exceed 0.6 ppm f¯. fluoride 1.0 mg tablets are contraindicated when the fluoride content of drinking water is >0.3 ppm f¯ and should not be administered to pediatric patients under 6 years. fluoride 0.5 mg tablets are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f¯ and should not be administered to pediatric patients under age 6 when the fluoride content of drinking water is 0.3 ppm f¯ or more or to pediatric patients under age 3 years. fluoride 0.25 mg tablets are contraindicated when the fluoride content of drinking water is more than 0.6 ppm f¯ and should not be administered to pediatric patients under age 3 years when the fluoride content of drinking water is 0.3 ppm f¯ or more. do not administer sodium fluoride chewable tablets (any strength) to pediatric patients under age 3 years. sodium fluoride chewable tablets (any strength) are not indicated for use in adults.